Eline Entertainment Group Inc. (OTCPK:EEGI)
Eline Entertainment Group, Inc. recently announced that the company has entered into merger discussions with China-based video game designer Vu365.
EEGI management feels that this is a significant event that merits reporting to the market. Management believes that this merger is imminent, as Vu365 (www.vu365.com) has been looking to enter the USA markets for quite some time, and virtually exhausted its patience in discussion with another publicly traded company. EEGI management being able to accommodate VU365 needs is taking aggressive action. According to sources, Vu365 offers revenues in the $2 million USD range, with profits of $500,000 USD.
Vu365, a China-based gaming company, has over 30 employees. Founded in 2005, the group operates web and casual games. Vu365 has several products in development: an assortment of strategic web games, cyber games and 3-D large scale competitive games. Vu365 has already garnered popularity as the sole agent of a Korean MMORPG (Massively Multiplayer Online Role-Playing Game), a game that accrued 3000 online gamers and a monthly residual income of almost 300,000 RMB (about $10,000.00 USD) from that single application alone.
In other company news, the EEGI board awaits Innovation Group (Inn) updates regarding diversification of the Inn assets. EEGI management is looking for a change in direction and growth with its focus set in the entertainment industry with the aforementioned pending merger of VU365; and the recent merger of USA based luxury leisure transportation services.
ATP Oil & Gas Corp. (Nasdaq:ATPG) will meet one-on-one with investors on November 11th and 12th in Chicago and Milwaukee. Chief Financial Officer Al Reese, Jr. will discuss the company-wide growth strategy and value. ATP Oil & Gas is focused on development and production of oil and natural gas in the Gulf of Mexico and the North Sea. The company trades publicly as ATPG on the NASDAQ Global Select Market.
Ebix Inc. (Nasdaq:EBIX) a leading international supplier of On-Demand software and E-commerce services to the insurance industry, reported record financial results for the third quarter of 2010. Total Q3 2010 revenue grew to a record $33.3 million, an increase of 43% on a year-over-year basis, as compared to Q3 2009 revenue of $23.3 million. During the nine months ended September 30, 2010 revenue increased $30.7 million or 46%, to $97.1 million compared to $66.4 million during the same period in 2009.
A leading international supplier of On-Demand software and E-commerce services to the insurance industry, Ebix, Inc., (NASDAQ:EBIX) provides end-to-end solutions ranging from infrastructure exchanges, carrier systems, agency systems and BPO services to custom software development for all entities involved in the insurance industry.
ARM Holdings plc (Nasdaq:ARMH) introduced at the ARM Technology Conference, Santa Clara CA., the CoreLink™ 400 series of AMBA® 4 protocol-compliant system IP, enabling system designers to realize the full potential of the latest high-performance CPU and GPU technology. The CoreLink 400 series maximizes the performance and efficiency for SoC compute systems required by advanced mobile, consumer and enterprise applications.
ARM designs the technology that lies at the heart of advanced digital products, from wireless, networking and consumer entertainment solutions to imaging, automotive, security and storage devices. ARM’s comprehensive product offering includes 32-bit RISC microprocessors, graphics processors, video engines, enabling software, cell libraries, embedded memories, high-speed connectivity products, peripherals and development tools
Power3 Medical Products, Inc. (OTC:PWRM)
PWRM recently delivered four poster presentations at the 2010 ICAD. These presentations discussed PWRM’s diagnostic test, NuroPro, and focused on PWRM’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.
“In preparation for commercialization, our objective at this meeting was to show how Power3’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief ScACientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”
“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” commented Helen R. Park, MS, CEO of PWRM, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”
“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for (thirty) days of advertising for Eline Entertainment Group, Inc. (OTCPK:EEGI).